CervoMed (CRVO) Dividends Paid - Common (2017 - 2018)
CervoMed (CRVO) posted Dividends Paid - Common of $85993.0 for Q1 2018, down 74.67% sequentially from $339448.0 in Q4 2017, and up 46.13% YoY from $58845.0 in Q1 2017.
CervoMed (CRVO) Dividends Paid - Common (2017 - 2018) Analysis & Trends
CervoMed has reported Dividends Paid - Common for 2 years, with the latest figure at $85993.0 in Q1 2018.
- Quarterly Dividends Paid - Common rose 46.13% year-over-year to $85993.0 in Q1 2018, while the trailing twelve-month figure through Dec 2018 was $85993.0 (down 93.38% YoY) and the FY2018 annual result came in at $85993.0, down 93.13% from the prior year.
- Dividends Paid - Common slipped to $85993.0 in Q1 2018 per CRVO's latest filing, from $339448.0 in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $500000.0 in Q2 2017 and troughed at $58845.0 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 34.60 Mn |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 85,993.00 |
| Mar 31, 2018 | 85,993.00 |
| Dec 31, 2017 | 339,448.00 |
| Dec 31, 2017 | 339,448.00 |
| Sep 30, 2017 | 400,000.00 |
| Sep 30, 2017 | 400,000.00 |
| Jun 30, 2017 | 500,000.00 |
| Jun 30, 2017 | 500,000.00 |
| Mar 31, 2017 | 58,845.00 |
| Mar 31, 2017 | 58,845.00 |